Genomic Health and Biocartis Announce Agreement to Develop an Idylla™ IVD Oncotype DX® Breast Cancer Test to Broaden Global Patient Access
Strategic Collaboration Aimed at Exclusive Test Development and Commercialization of Proprietary Genomic Health Tests on the Idylla™ Platform
Page (1) of 1 - 09/13/17||
(September 13, 2017)
[ServletException in:/common/layout/us_view_template.jsp] null'